Julia Fan Li

Julia Fan Li is Co-Founder & CEO of Micrographia Bio, an AI-first life sciences company with a mission to deliver a new era of drug discovery using spatial proteomics. Prior to Micrographia Bio, she was at the forefront of the genomics revolution, leading scale-up efforts for Seven Bridges Genomics in the UK. 

​

Stemming from her PhD in innovative finance for global health at Cambridge University, she previously was Co-Founder of the Global Health investment Fund - a pioneering $108mm late-stage venture fund to invest in therapeutics, vaccines, diagnostics and devices for diseases which disproportionately affect low and middle-income countries. The GHIF (now part of GHIC) was launched at UNGA in September 2013 by Bill Gates and Jamie Dimon. 

​

Julia obtained her B.Comm (double major in finance and immunology) from UBC and worked in healthcare financial services as a Chartered Accountant across four continents. She is passionate about drug discovery and innovative finance structures that can accelerate biomedical R&D. In the community, Julia serves on the Board of Trustees of the Gates Cambridge Scholarships at the University of Cambridge and the London TELUS community board. 

A member of Class 20, Julia completed her fellowship under the mentorship of Christopher Egerton-Warburton, Partner at Lion's Head Global Partners.